Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinrong Fan

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Journal of Magnetic Resonance Imaging : JMRI|July 2, 2026
A Quantitative Modification of VI-RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience LevelsErjia Guo, Li Chen, Yongliang Li, et al.
Psychopharmacology|July 7, 2026
Sotagliflozin pretreatment attenuates acute LPS-induced depression-like behavioral abnormalities and modulates the gut microbiota-immune-brain axisJun Zeng, Lihuimei Zhou, Lei Liao, et al.
Endocrine|March 3, 2023
Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective studyLingge Wu, Yan Xu, Xiang Wang, et al.
Cancer Medicine|April 6, 2023
Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 studySujun Han, Zhigang Ji, Junhui Jiang, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Journal of Magnetic Resonance Imaging : JMRI|July 2, 2026
A Quantitative Modification of VI-RADS for Bladder Cancer at the Ureteral Orifice: A Reader Study on MRI With Varying Experience LevelsErjia Guo, Li Chen, Yongliang Li, et al.
Psychopharmacology|July 7, 2026
Sotagliflozin pretreatment attenuates acute LPS-induced depression-like behavioral abnormalities and modulates the gut microbiota-immune-brain axisJun Zeng, Lihuimei Zhou, Lei Liao, et al.
Endocrine|March 3, 2023
Thyroid dysfunction after immune checkpoint inhibitor treatment in a single-center Chinese cohort: a retrospective studyLingge Wu, Yan Xu, Xiang Wang, et al.
Cancer Medicine|April 6, 2023
Neoadjuvant therapy with camrelizumab plus gemcitabine and cisplatin for patients with muscle-invasive bladder cancer: A multi-center, single-arm, phase 2 studySujun Han, Zhigang Ji, Junhui Jiang, et al.
Pageof 7